BIOMAT Database Logo BIOMAT Database Logo

Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection. 1990

N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Department of Medicine, School of Veterinary Medicine, University of California, Davis 95616.

Preexistent feline leukemia virus (FeLV) infection greatly potentiated the severity of the transient primary and chronic secondary stages of feline immunodeficiency virus (FIV) infection. Of 10 FeLV-FIV carrier cats, 5 died of experimentally induced FIV infection, compared with 2 deaths in 10 cats infected only with FeLV and 1 death in 7 cats infected only with FIV. FIV-infected cats with preexistent FeLV infections developed severe depression, anorexia, fever, diarrhea, dehydration, weight loss, and leukopenia 4 to 6 weeks after infection and were moribund within 2 weeks of the onset of signs, whereas cats infected only with FIV developed much milder self-limiting gross and hematologic abnormalities. Pathologic findings in dually infected cats that died were similar to those observed previously in cats dying from uncomplicated primary FIV infection but were much more widespread and severe. Coinfection of asymptomatic FeLV carrier cats with FIV did not increase the levels of FeLV p27 antigen present in their blood over that seen in cats infected with FeLV alone. The amount of proviral FIV DNA was much higher, however, in dually infected cats than in cats infected only with FIV; there was a greater expression of FIV DNA in lymphoid tissues, where the genome was normally detected, and in nonlymphoid tissues, where FIV DNA was not usually found. Dually infedted cats that recovered from the primary stage of FIV infection remained more leukopenic than cats infected with FIV or FeLV alone, and their CD4+/CD8+ T-lymphocyte ratios were inverted. One of these cats developed what was considered to be an opportunistic infection. It was concluded, therefore, that a preexistent FeLV infection in some way enhanced the expression and spread of FIV in the body and increased the severity of both the resulting transient primary and chronic secondary stages of FIV infection. This study also demonstrated the usefulness of the FIV model in studying the role of incidental infectious diseases as cofactors for immunodeficiency-causing lentiviruses.

UI MeSH Term Description Entries
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005256 Leukemia Virus, Feline A species of GAMMARETROVIRUS causing leukemia, lymphosarcoma, immune deficiency, or other degenerative diseases in cats. Several cellular oncogenes confer on FeLV the ability to induce sarcomas (see also SARCOMA VIRUSES, FELINE). Cat Leukemia Virus,FeLV,Feline Lymphoma Virus,Feline Leukemia Virus,Cat Leukemia Viruses,Feline Leukemia Viruses,Feline Lymphoma Viruses,Leukemia Virus, Cat,Leukemia Viruses, Cat,Leukemia Viruses, Feline,Lymphoma Virus, Feline,Lymphoma Viruses, Feline
D005260 Female Females
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene

Related Publications

N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Lymphosarcoma in experimentally induced feline immunodeficiency virus infection [corrected].
April 1992, The Veterinary record,
N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.
August 1988, American journal of veterinary research,
N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Malignant lymphoma associated with experimentally induced feline immunodeficiency virus infection.
May 1994, Journal of comparative pathology,
N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Evaluation of cofactor effect of feline syncytium-forming virus on feline immunodeficiency virus infection.
May 1993, American journal of veterinary research,
N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Clinical aspects of feline immunodeficiency and feline leukemia virus infection.
October 2011, Veterinary immunology and immunopathology,
N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Identification of a cellular cofactor required for infection by feline leukemia virus.
March 2000, Science (New York, N.Y.),
N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
November 1991, Journal of the American Veterinary Medical Association,
N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Feline leukemia virus and feline immunodeficiency virus.
September 2000, The Veterinary clinics of North America. Small animal practice,
N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Feline leukemia virus & feline immunodeficiency virus.
April 1996, The veterinary quarterly,
N C Pedersen, and M Torten, and B Rideout, and E Sparger, and T Tonachini, and P A Luciw, and C Ackley, and N Levy, and J Yamamoto
Quantification of lymphadenopathy in experimentally induced feline immunodeficiency virus infection in domestic cats.
May 1995, Veterinary immunology and immunopathology,
Copied contents to your clipboard!